Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Elite Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 659.6K | 0 | −659.6K (−100.0%) |
| Value | $24.0K | $0 | −$24.0K (−100.0%) |
New holders (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (2)
Institutions that held Elite Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Blackston Financial Advisory Group, LLC | 577,605 | $21.0K |
| Fisher Asset Management, LLC | 82,000 | $3.00K |